LPLuis Flavio Fabrini Paleare

Luis Flavio Fabrini Paleare

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Luis Flavio Fabrini Paleare has a total of 61 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Ozzy Osbourne and Parkinson's disease: from darkness to awareness

    by Luis F. Fabrini Paleare, José Luiz Pedroso, Flávia de Paiva Santos Rolim, Natália R. Karpejany, Carlos Henrique Ferreira Camargo, Hélio A. G. Teive, Gustavo L. Franklin

    Ozzy Osbourne, the legendary frontman of Black Sabbath, publicly revealed his diagnosis of Parkinson's disease (PD) in 2020, offering visibility to a complex neurodegenerative condition. His case, later linked to a mutation in the PARK2 (parkin) gene, presented atypically with a later age of onset, contributing to ongoing discussions about the phenotypic variability of genetic forms of PD. Beyond medical narratives, Osbourne's openness and philanthropy—culminating in a benefit concert that raised $190 million for Parkinson's and pediatric charities—played a transformative role in destigmatizing the disease. This article explores the scientific and social impact of Osbourne's disclosure, highlighting the role of PARK2 in mitochondrial homeostasis, synaptic integrity, and tumor suppression. We also examine his pursuit of experimental stem cell therapy, discussing its scientific basis, ethical considerations, and current clinical research landscape.

  • Open Access

    Cerebral palsy in art and literature throughout history

    by Patricia Do Rocio Litça, Ana C. de Souza Crippa, Adrielle Holler Pykocz, Luis F. Fabrini Paleare, Marcio Vieira Sanches Silva, Filipe M. Barcelos, Helio A. G. Teive, Gustavo Leite Franklin

    Cerebral palsy (CP), a term coined by William John Little in 1843, represents a group of non-progressive motor disorders resulting from early brain injury. Beyond its medical characterization, there were early artistic depictions, such as Egyptian reliefs and medieval religious scenes, portraying individuals with asymmetric or contracted limbs mainly through symbolic or moral lenses. During the Renaissance and Baroque periods, artists including Dürer and Velázquez subtly represented physical diversity, though without explicit medical context. Literary portrayals evolved from mythological or moral allegory (e.g., Hephaestus, hagiographies) to empathetic narratives of individuality and inclusion, as seen in Tiny Tim, present in A Christmas Carol, written by Charles Dickens, and Draper's Out of My Mind. In modern times, artists and writers living with CP transformed disability into a means of self-expression and social critique.

  • Adipose-Derived Stem Cells in Traumatic Brain Injury: A Systematic Review of Preclinical Studies

    by Marcio Yuri Ferreira, Luis F. Fabrini Paleare, Yasmin P. Silva, Kaike Lobo, Leonardo Januário Campos Cardoso, Christian Ken Fukunaga, Ary Rodrigues Neto, José da Conceição Carvalho, Gustavo L. Franklin, Lydia Masako Ferreira, et al.

    Background Although traumatic brain injury (TBI) is a significant cause of morbidity and mortality worldwide, there have been few significant therapeutic advances in recent years. Preclinical studies have explored the potential of adipose-derived stem cells (ADSCs) to improve neural function and reduce brain damage in animal models following TBI. This systematic review aims to assess and synthesize the current evidence on the efficacy of ADSCs in animal models with induced TBI. Methods Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we systematically searched Scopus, PubMed, Web of Science, and Cochrane Library from inception to July 7, 2024, for original, English-language studies on animal models of induced TBI treated with ADSCs. We excluded in vitro, in silico, studies involving humans, and conference abstracts. Risk of bias was assessed using the Systematic Review Centre for Laboratory Animal Experimentation (SYRCLE) tool. Results Twenty-two studies met the inclusion criteria. The most common routes of ADSC administration were intravenous and intracerebral injections, typically given within 24 h of induced TBI. Histological and neuroimaging assessments showed reduced tissue swelling and interstitial fluid accumulation in ADSC-treated animals, indicating decreased brain vasogenic edema. ADSC treatment also reduced neuroinflammation markers, suggesting lower activation of astrocytes and microglia around the injury site associated with M2 microglial phenotype polarization. Enhanced neurogenesis was observed, particularly in the hippocampus, with markers like bromodeoxyuridine (BrdU) and neuronal nuclei (NeuN) indicating improved neuron formation. Consistent cognitive and motor improvements were also noted, with treated animals showing shorter escape times and path lengths in spatial memory tests (e.g., Morris Water Maze) and better motor coordination in beam tests. Conclusion The available pre-clinical in vivo evidence indicates that ADSC-based therapies have the potential to mitigate neuroinflammation, reduce brain edema, enhance neurogenesis, and improve functional outcomes following induced TBI. Clinical studies are warranted to investigate the use of ADSCs in the treatment of TBI in humans.


  • Bibliometric analysis of neurointerventional surgery: The scientific production of the specialty in the two leading specialty-specific journals

    by Leonardo Bo Brenner, Victor Arthur Ohannesian, Bernardo Vieira Nogueira, João Artur Mateus Linhares, Sávio Batista, João Marcelo Baptista, Raphael Camerotte, Luis F Fabrini Paleare, Pedro Henrique Cieslak, Raphael Bertani

    Introduction: In recent decades, neurovascular practice has shifted from open surgical procedures to interventional neuroradiology. Within this evolving landscape, two journals—Interventional Neuroradiology (INR) and Journal of NeuroInterventional Surgery (JNIS)—have become central platforms for disseminating impactful research. Methods: A bibliometric analysis was conducted using the Scopus database to identify the 500 most cited articles published in Interventional Neuroradiology (INR) and the Journal of NeuroInterventional Surgery (JNIS). Each article was categorized by study type, procedure, and pathology. Bibliometric data were analyzed using R and VOSviewer to map influential studies and collaborative networks within the field. Results: A total of 6813 articles were screened. The 500 most cited, comprising 439 from JNIS and 61 from INR, were analyzed. Citation counts averaged 70.71 per article, with the top-cited study reaching 371 citations. A marked increase in high-impact publications occurred from 2020 to 2024, reflecting growing output in the field. The United States led in total publications and citations. Trending topics evolved from early focuses on pediatric cases and aneurysms to current emphases on stroke, thrombectomy, flow diverters, and artificial intelligence. This was confirmed by keyword analysis, demonstrating the dominance of cerebrovascular pathology and minimally invasive techniques in recent neurointerventional research. Conclusion: This analysis highlights the central role of ischemic stroke and aneurysm treatment in neurointervention, with thrombectomy and endovascular therapies driving clinical advances. The field shows increasing global engagement and a shift toward higher-level evidence, reflecting its maturation. While foundational studies remain influential, recent research is poised to define future directions and innovation.

  • Top Cited Papers

    Thrombolysis for Ischemic Stroke Beyond the 4.5-Hour Window: A Meta-Analysis of Randomized Clinical Trials

    by Ahmet Günkan, Marcio Yuri Ferreira, Marina Vilardo, Luca Scarcia, Jhon E. Bocanegra-Becerra, Leonardo Januario Campos Cardoso, Luis F. Fabrini Paleare, Gustavo de Oliveira Almeida, Gabriel Semione, Christian Ferreira, et al.

    BACKGROUND: A minority of patients with stroke qualify for intravenous thrombolysis (IVT) within 4.5-hour window. The safety and efficacy of IVT beyond this period have not been well studied. METHODS: We systematically searched MEDLINE, Embase, Cochrane, and ClinicalTrials.gov for relevant randomized clinical trials. Randomized clinical trials comparing IVT versus standard medical care in patients with ischemic stroke beyond 4.5 hours of symptom onset or last known well without mechanical thrombectomy (MT) were included. Primary outcomes were excellent (modified Rankin Scale score of 0–1) and good (modified Rankin Scale score of 0–2) functional outcomes at 90 days, symptomatic intracerebral hemorrhage (sICH), and death at 90 days. Pooled odds ratios (ORs) with 95% CIs were calculated using a random-effects model. Heterogeneity was assessed by Q test and quantified by I ² values. RESULTS: Eight randomized clinical trials (1742 patients; mean age, 69.8±9 years, 63.5% men) were included. Compared with standard medical care, IVT achieved higher rates of excellent (OR, 1.43 [95% CI, 1.17–1.75]; Q =2.30; P =0.94; I 2 =0%) and good functional outcomes (OR, 1.36 [95% CI, 1.12–1.66]; Q =2.07; P =0.96; I 2 =0%) at 90 days but also increased sICH rates (OR, 4.25 [95% CI, 1.67–10.84], Q =0.48; P =0.99; I 2 =0%). Mortality at 90 days did not significantly differ between treatment groups (OR, 1.28 [95% CI, 0.87–1.89]; Q =4.63; P =0.59; I 2 =0%). Subanalyses yielded numerically higher odds of excellent functional outcomes when patients were selected with perfusion imaging (3 studies, OR, 1.45 [95% CI, 1.08–1.94]) compared with diffusion-weighted imaging–fluid-attenuated inversion recovery mismatch (3 studies, OR, 1.34 [95% CI, 0.94–1.91]) and when treated with tenecteplase (3 studies, OR, 1.47 [95% CI, 1.06–2.04]) compared with alteplase (5 studies, OR, 1.38 [95% CI, 1.08–1.78]). CONCLUSIONS: IVT for ischemic stroke beyond 4.5 hours, without MT, led to increased odds of excellent and good functional outcomes compared with standard medical care, despite higher odds of sICH, and a nonsignificant numerical increase in mortality.


  • The Evolving Role of Palliative Care in Older People with Glioblastoma

    by Inibehe Ime Okon, Mahmoud Osama, Asangaedem Akpan, Luis Flavio Fabrini Paleare, Márcio Yuri Ferreira, Muhammad Danish Shafqat, Youssef Razouqi, Emmanuel James, Mohammad Omer, Ibrahim Khalil Ja'AFar, et al.